Literature DB >> 9122714

The role of inflammatory cells and their proteases in extravascular fibrinolysis.

M Heiden1, R Seitz, R Egbring.   

Abstract

Extravascular fibrin formation and dissolution is a pivotal event in numerous inflammatory and malignant diseases. In inflammatory cells such as monocytes/macrophages, neutrophil granulocytes appear to interact intimately with hemostasis and regulate the activity of the cascade systems of coagulation and fibrinolysis. Proteases such as neutrophil elastase are thought to influence components of hemostasis, and furthermore provide an alternative pathway of fibrinolysis. Histological, experimental, and clinical data suggest that extravascular fibrinolysis, mediated both by the plasmin system and by proteases like neutrophil elastase, is a prominent finding in various diseases such as lung cancer, chronic inflammatory bowel disease, vasculitis and connective tissue disease, bacterial sepsis, and septic shock.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9122714     DOI: 10.1055/s-2007-999050

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  3 in total

Review 1.  Inflammation in Cerebral Venous Thrombosis.

Authors:  Jiayue Ding; Baoying Song; Xiran Xie; Xaingyu Li; Zhiying Chen; Zhongao Wang; Liqun Pan; Duo Lan; Ran Meng
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

2.  A new assay to evaluate microvesicle plasmin generation capacity: validation in disease with fibrinolysis imbalance.

Authors:  Sylvie Cointe; Karim Harti Souab; Tarik Bouriche; Loris Vallier; Amandine Bonifay; Coralie Judicone; Stéphane Robert; Romain Armand; Philippe Poncelet; Jacques Albanese; Françoise Dignat-George; Romaric Lacroix
Journal:  J Extracell Vesicles       Date:  2018-07-16

3.  Thromboinflammation in COVID-19: Can α2 -macroglobulin help to control the fire?

Authors:  Rainer Seitz; Lutz Gürtler; Wolfgang Schramm
Journal:  J Thromb Haemost       Date:  2020-12-19       Impact factor: 16.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.